You can be part of the Future of veterinary medicine

NASDAQ: KIN

We love the pets around us – our dogs and cats we share our lives with. Many of us believe these animals are part of the family, providing us unconditional love and companionship throughout our lives. We have an opportunity for cutting edge treatment when disease and chronic conditions cross our path, but what happens when our pets encounter these same issues?

Treatment options for our pets shouldn’t be limited

KindredBio has a deep and innovative pipeline for the veterinary industry

Learn More about Analyst Ratings and Earnings on

Download the Corporate Presentation to learn more about our strategy, team, and programs.

KindredBio-Corporate-Presentation_3.16.2021-Final

Looking for More?

The Management Team

We have a world class leadership team guiding us in our quest to develop the best medicines for our best friends.

See Our Pipeline

KindredBio has an exciting pipeline of high-value products for dogs and cats in development.

NASDAQ: KIN

News

  • Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK StudyApril 20, 2021 - 4:05 pm
  • Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial ResultsMarch 16, 2021 - 4:05 pm
  • Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsMarch 8, 2021 - 8:40 am

Events

  • Event: Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsMarch 8, 2021 - 8:48 am
  • Event: Kindred Biosciences to Present at the H.C. Wainwright Global Life Sciences ConferenceMarch 2, 2021 - 8:45 am
  • Event: Kindred Biosciences to Present at the Barclays Global Healthcare ConferenceMarch 2, 2021 - 8:43 am
$4.71 Stock is Up 0.06 (1.29%)
KIN (Common Stock)
Previous Close Volume
$4.65 509,901
Intraday High Intraday Low
$4.76 $4.48
52 Week High 52 Week Low
$6.00 $3.20
Exchange: NASDAQ CM
Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements
© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010
Scroll to top